Principal Financial Group Inc. Sells 2,005,068 Shares of Healthpeak Properties, Inc. $DOC

Principal Financial Group Inc. lowered its position in Healthpeak Properties, Inc. (NYSE:DOCFree Report) by 10.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 16,760,575 shares of the real estate investment trust’s stock after selling 2,005,068 shares during the quarter. Principal Financial Group Inc. owned 2.43% of Healthpeak Properties worth $358,678,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in DOC. Integrated Wealth Concepts LLC grew its holdings in Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after acquiring an additional 1,231 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Healthpeak Properties by 110.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock worth $2,463,000 after purchasing an additional 63,930 shares during the period. Woodline Partners LP lifted its holdings in shares of Healthpeak Properties by 41.3% during the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock worth $1,195,000 after purchasing an additional 17,279 shares during the period. Brown Advisory Inc. grew its stake in shares of Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock worth $819,000 after purchasing an additional 1,415 shares during the last quarter. Finally, Qube Research & Technologies Ltd bought a new stake in shares of Healthpeak Properties in the second quarter worth $3,117,000. Institutional investors own 93.57% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on DOC shares. Weiss Ratings restated a “hold (c)” rating on shares of Healthpeak Properties in a report on Wednesday, August 5th. Evercore lowered Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target on the stock. in a research report on Monday, May 11th. Cantor Fitzgerald increased their price target on Healthpeak Properties from $20.00 to $23.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Robert W. Baird raised their price objective on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $22.00 price objective (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Four analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company. According to MarketBeat, Healthpeak Properties presently has a consensus rating of “Hold” and a consensus price target of $21.44.

Check Out Our Latest Research Report on Healthpeak Properties

Healthpeak Properties Price Performance

DOC stock opened at $20.78 on Friday. The firm has a market cap of $14.33 billion, a price-to-earnings ratio of 59.38, a PEG ratio of 3.20 and a beta of 1.01. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. Healthpeak Properties, Inc. has a 12-month low of $15.70 and a 12-month high of $22.95. The company’s fifty day simple moving average is $21.33 and its 200 day simple moving average is $18.90.

Healthpeak Properties (NYSE:DOCGet Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business had revenue of $771.58 million for the quarter, compared to analysts’ expectations of $725.64 million. During the same quarter in the prior year, the firm posted $0.46 earnings per share. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, analysts expect that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a dividend yield of 5.9%. Healthpeak Properties’s dividend payout ratio is presently 348.57%.

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

See Also

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOCFree Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.